about
Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndromeLoss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac deathCommon variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathElectrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms.Short QT Syndrome: a familial cause of sudden death.Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome.Short QT syndrome.Clinical characteristics and treatment of short QT syndrome.Short QT syndrome. Genotype-phenotype correlationsShort QT syndrome: clinical findings and diagnostic-therapeutic implications.[Short QT syndrome].Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.Clinical and molecular genetics of the short QT syndrome.Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome.Is a narrow and tall QRS complex an ECG marker for sudden death?Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.Prevention of inappropriate ICD shocks in patients with Brugada syndrome.Risk stratification in electrical cardiomyopathies.Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2Long-term follow-up of patients with short QT syndrome.Early repolarization pattern: a marker of increased risk in patients with catecholaminergic polymorphic ventricular tachycardia.Short QT Syndrome - Review of Diagnosis and Treatment.PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome?Sudden death associated with short-QT syndrome linked to mutations in HERG.Short QT syndrome: pharmacological treatment.Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients.Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERGMolecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide.Electromechanical coupling in patients with the short QT syndrome: further insights into the mechanoelectrical hypothesis of the U wave.Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.Short QT syndrome. Update on a recent entity.ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome.
P50
Q24300388-43E45F09-B1C0-439D-8008-C17324D66241Q24675134-9E538B14-2E94-477C-8B28-B698F1503F37Q28294931-88C99925-E255-4466-8DF5-B111FEAF5FAAQ30320151-BDA02906-4669-4224-886D-BDEBB1E222BBQ33149259-9F258A18-85EC-4318-8948-5C4553169EBEQ33150805-34DEDAB0-DB33-49CA-81CF-B3A53C0DF4FEQ33152228-2FB89AC5-8214-47B2-BCB2-51DCEB55B199Q33152684-F095865F-0BCD-4E97-B7CD-3A54BEE5E838Q33152955-9095DF8C-6A98-47C4-8BC9-200B6F6813FEQ33153179-C38D12ED-9E76-4BE1-AC52-816430B085EAQ33154179-8A350369-57AB-4AAD-835A-202BC32507AFQ33155122-B80E5EE2-706B-4E58-98E8-AE98C7F41880Q33155155-A25E9E8C-2810-4AEF-BA2C-EB36B48F681AQ33156151-F49B6F9F-1386-40A1-9DDD-925F38419879Q33156554-99EE3911-5C87-4136-B78E-846D9192DCA8Q33156610-11A2BB5F-DD27-49FB-B04F-989C6E6B914EQ33157573-67225ECC-0B31-4B59-82DB-3E9159388E9AQ33157823-82D25412-0B00-48B4-A400-6F2341B2FCC8Q33158278-BA46443A-AAC7-44B3-9347-BFFC2EBC507CQ33159536-89D3DFD6-C06B-4C7C-A989-1FF53552A93BQ33160301-71A236A1-E394-4276-A108-A5F073C6D486Q33166611-AC15AA72-9E00-4DAF-B4AB-84FBBD9643EFQ33166770-0BE989E6-6760-4D07-86E3-AAA5D782B933Q33942230-5E79E53D-E45B-4DF6-9569-DE3540E5AAB1Q34283788-31218BFF-DE26-4890-9DA7-2A335A0BACF7Q34314532-AB925DFA-D3F9-4726-B96C-8EC4A75F3DD5Q34395488-EE1A37F5-3120-4256-AE9C-EBFD185DE5DDQ34413880-688E9B90-B910-4791-9398-260DE72FD04BQ34461751-5BDD8FCE-22E2-4625-881E-703461C582D2Q34658771-34686C43-AFE2-4A5D-89FA-B7142EFC13E4Q34661923-72DAC3B5-D70E-41B2-996A-F1A2342BBFD6Q35782882-29ECF25D-2389-4579-8141-3D42902C4E24Q35907195-49555F6F-04FF-4DB7-9DC2-C3591DE0DADBQ36351042-67C5A1B3-E1B2-45E1-A115-A2D8C7244E17Q36631322-10D35B2F-C37B-4E2D-B16F-1F73B38E96D1Q37240660-B1B51E7F-BC88-46D2-BB39-A660659BBD6AQ37342308-000C7270-AC66-4701-BDED-023457034BD5Q37627289-779864A9-36CC-4FC1-AA6E-242F15E9BDB5Q41670602-E651FFED-FFB5-49A4-87AF-877B44ACE07CQ42912081-0BC769FE-E91C-4F88-B083-EA16E24F7789
P50
name
Rainer Schimpf
@en
type
label
Rainer Schimpf
@en
prefLabel
Rainer Schimpf
@en